Clinical Trials Logo

Filter by:
NCT ID: NCT04238793 Active, not recruiting - Clinical trials for Lumbosacral Radiculopathy

Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

Start date: March 10, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Escalating single-dose design study to determine the safety, tolerability, and analgesic activity of KLS-2031

NCT ID: NCT04238455 Active, not recruiting - Thoracic Surgery Clinical Trials

Ultrasound-Guided Serratus Anterior Plane Block for Additional Pain Relief After Lung Surgery

Start date: January 22, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to see if an anesthesia technique called serratus anterior plane block may provide additional pain relief for the chest wall after lung surgery. The study will evaluate the effect the serratus anterior plane block technique has on the need for opioids after surgery,the level of pain during recovery, and other aspects of recovery, like whether the patient has nausea and their ability to breathe deeply. The effects of the serratus anterior plane block will be compared to the effects of an inactive (sham) block.

NCT ID: NCT04238247 Active, not recruiting - Accident, Traffic Clinical Trials

Tiny Cargo, Big Deal! An ED-Based Study of Child Passenger Safety Behaviors

Start date: January 28, 2020
Phase: N/A
Study type: Interventional

This study involves an emergency department (ED)-based intervention utilizing Motivational Interviewing (MI) techniques and patient-centered eHealth materials (e.g., a tailored, mobile-friendly website and text messages) to promote the correct and consistent use of size-appropriate child passenger restraints (car seats, booster seats, and seat belts). This study is designed as an adaptive randomized controlled trial, recruiting English and Spanish speaking caregivers of children 6 months to 10 years old.

NCT ID: NCT04237753 Active, not recruiting - Clinical trials for Urinary Incontinence

Remote Access to Urinary Incontinence Treatment for Women Veterans

PRACTICAL
Start date: April 6, 2020
Phase: N/A
Study type: Interventional

This study is about assessing the helpfulness of two treatment delivery methods for bladder leakage or urinary incontinence. It is being funded by the Department of Veterans Affairs. By doing this study, the investigators hope to learn which treatment method is the most helpful remote delivery method for treating bladder leakage. The total participation time in this research is 6 months. During the first 8 -12 weeks of the study, you will receive standard of care from an online educational program (MyHealtheBladder) or a video visit with a provider through VA Video Connect. You will be selected by chance to receive MyHealtheBladder or VA Video Connect. About half-way through the study, the investigators will ask you about your bladder symptoms. If your bladder symptoms are not better, you will be selected by chance to continue the previous treatment or receive an initial or booster video session with a provider. Throughout the study, you will be asked to answer questions related to your health, bladder leakage, costs due to bladder leakage, and track your behavioral training.

NCT ID: NCT04237688 Active, not recruiting - Clinical trials for Myocardial Infarction

ECG Methods for the Prompt Identification of Coronary Events

EMPIRE
Start date: May 1, 2013
Phase:
Study type: Observational

There is a clear need to develop improved tools to stratify risk in patients who seek emergency care for chest pain, one of the most common and potentially deadliest conditions encountered in acute care settings. The ECG has been the mainstay of initial evaluation of chest pain patients, yet is currently only diagnostic for a small subset of patients with ST-elevation myocardial infarction. Prior studies have identified candidate markers of ECG characteristics and preliminary algorithms that can identify patients with non-ST elevation myocardial infarction as well as those with very low risk of coronary artery disease. This study will enroll a cohort of consecutive chest pain patients needed to confirm the accuracy of these ECG markers and determine their maximal clinical utility as part of a risk stratification tool. With these improved tools, emergency providers (physicians, nurses, and paramedics) will be able to streamline the care provided to these patients beyond the costly and time-consuming overnight observation for serial cardiac enzymes and provocative testing.

NCT ID: NCT04237545 Active, not recruiting - Edentulous Jaw Clinical Trials

A Clinical Study of the T3 Short Dental Implant System

Magnolia
Start date: October 1, 2019
Phase: N/A
Study type: Interventional

This clinical study will evaluate the safety and performance of the T3 short dental implant when placed in the posterior maxilla and mandible.

NCT ID: NCT04236986 Active, not recruiting - Clinical trials for Post Traumatic Stress Disorder

Imaging the Neuroimmune System in PTSD

Start date: March 28, 2017
Phase: Phase 1
Study type: Interventional

In this study, individuals with and without post-traumatic stress disorder (PTSD) will undergo one positron emission tomography (PET) scan using the radiotracer [11C]PBR28, which binds to the 18kDa translocator protein (TSPO). A subset of individuals who complete the first PET [11C]PBR28 scan will be invited to complete an inflammatory challenge and second PET [11C]PBR28 scan. Approximately 3 hours prior to the second [11C]PBR28 PET scan, lipopolysaccharide (LPS; endotoxin) will be administered to evoke a robust neuroimmune response. Subjects will also undergo behavioral and cognitive testing. Vital signs, subjective response, and peripheral biomarker levels will be assayed periodically throughout the experimental session. Specific aims: 1) Determine if individuals with PTSD exhibit neuroimmune system disruption relative to well-matched comparators at baseline. 2) Determine if individuals with PTSD exhibit a disrupted neuroimmune response after a classical immune stimulus relative to well-matched comparators. 3) Determine if LPS differentially alters cognitive function, subjective response, or physiological markers in individuals with PTSD compared to well-matched comparators. Hypothesis: Individuals with PTSD will exhibit a suppressed neuroimmune system at baseline and an attenuated neuroimmune response following LPS challenge, relative to matched trauma controls.

NCT ID: NCT04236882 Active, not recruiting - Behavioral Disorder Clinical Trials

Sleep and Physical Activity Intervention for Increasing Physical Activity in Overweight or Obese and Sedentary African Americans

Start date: October 4, 2019
Phase: N/A
Study type: Interventional

This trial studies how well sleep and physical activity interventions work in increasing the physical activity of overweight or obese and sedentary African Americans. Sleep and physical activity interventions may help to increase physical activity among overweight and obese African American adults who do not get enough exercise.

NCT ID: NCT04236804 Active, not recruiting - Clinical trials for Chronic Low-back Pain

Implementing TMC-CP01 Treatment Based on the Virtual Autonomic Neuromodulation Induced Systemic Healing System in Reducing Pain and Opioid Requirement in Subjects Suffering From Chronic Low Back Pain

VANISH
Start date: June 17, 2020
Phase: N/A
Study type: Interventional

The program, called TMC-CP01, will use a combination of virtual reality, biofeedback, and psychological exercises to manage pain associated with Chronic Low Back Pain. Chronic pain affects an estimated 100 million Americans, around one-third of the U.S. population. One of the most prevalent conditions under chronic pain is Chronic Low Back Pain (CLBP). About 27% of chronic pain patients experience CLBP. It is the leading cause of disability in the world and 31 million Americans suffer from CLBP. The most common analgesic tool for pain patients, especially for LBP patients, is opioids. However, opioid users are subject to drug tolerance and physical dependence, which decreases efficacy and increases risk of complication. Long-term users often require doses up to ten times their original dose to achieve equivalent analgesia and, after months of exposure, patients' risk of addiction increases. This project aims to introduce a digital intervention to standard CLBP management with a virtual reality-enabled pain management system that will improve pain management and decrease daily dosages of opioids.

NCT ID: NCT04236479 Active, not recruiting - Clinical trials for Congenital Heart Disease (CHD)

Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP)

Start date: July 29, 2020
Phase: Phase 1
Study type: Interventional

The proposed study will be a prospective, open-label, single-center, safety and feasibility phase 1 trial of allogeneic bone marrow-derived mesenchymal stromal cell (BM-MSC) delivery though cardiopulmonary bypass (CPB) using a homogeneous population of infants with congenital heart disease (CHD) who will be undergoing a two-ventricle repair within the first six months of life